Servica Oy has awarded a €30M framework for tubeless and tube-based hybrid insulin pumps and continuous glucose sensors to multiple suppliers across four lots

Servica Oy, a public undertaking operating in general public services, on behalf of Etelä-Savon hyvinvointialue, Pohjois-Karjalan hyvinvointialue and Pohjois-Savon hyvinvointialue, has awarded a framework agreement for tubeless and tube-based hybrid pumps and glucose sensors for continuous real-time sensing (Letkulliset ja letkuttomat hybridipumput ja glukoosisensorit jatkuvaan ajantasaiseen sensorointiin) to multiple suppliers. The value of all contracts awarded in this notice is €30,000,000.00, covering medical equipment, pharmaceuticals and personal care products, with an unlimited duration starting from 4 September 2026. The contract was awarded following an open procedure under the standard regime, governed by EU Directive 2014/24/EU.

Introduction

Servica Oy, a public undertaking operating in general public services, acting as group leader and central purchasing body, on behalf of Pohjois-Savon hyvinvointialue, Etelä-Savon hyvinvointialue and Pohjois-Karjalan hyvinvointialue, has conducted an open procedure for tubeless and tube-based hybrid pumps and glucose sensors for real-time monitoring, for use both with hybrid pumps and as independent meters. The procurement is divided into four lots: OSA 1 (Tubeless hybrid pump), OSA 2 (Tube-based hybrid pump), OSA 3 (Sensors for continuous real-time sensing, i.e. separate glucose monitoring), and OSA 4 (Option: medical supply distribution and ordering system).

The procurement is not financed with EU funds but is covered by the Government Procurement Agreement (GPA). Strategic procurement includes a social objective of human rights due diligence in global supply chains. The award criterion for all lots is price (100%), calculated by formula. All tenderers meeting the minimum requirements are selected as suppliers for the lots; tenders are prioritised based on the points obtained in the comparison, which compares the annual cost of the device and consumables. The final decision on the pump given to a patient is always made on medical grounds in the treating unit. Contracts are made for an indefinite period. The procurement value has been calculated with a 4-year consumption estimate. Contracts can be combined by lot if a tenderer offers and is selected for multiple lots. Contracts were concluded between 4 and 17 September 2026. Winners include NordicInfu Care AB - Filial Finland, mylife Diabetes Care Finland Oy, Medtronic Finland Oy, Rubin Medical Oy, Abbott Oy, Mediq Suomi Oy and Roche Diagnostics Oy. Subcontracting was declared for several winners.

Why This Contract Matters

This framework ensures that the wellbeing services counties of Pohjois-Savo, Etelä-Savo and Pohjois-Karjala have access to a broad range of hybrid insulin pumps and continuous glucose sensors for diabetes care.

This contract matters because it:

• Supports Diabetes Care: Provides hybrid insulin pumps and continuous glucose sensors
• Significant Value: €30,000,000.00 value of all contracts awarded in this notice
• Long-Term Commitment: Contracts made for an indefinite period
• Four Lots: Tubeless hybrid pump, tube-based hybrid pump, sensors, and optional distribution
• Price Focus: 100% price-based evaluation
• Strong Competition: 2 to 11 tenders per lot
• Strategic Procurement: Human rights due diligence in global supply chains
• Subcontracting: Declared for several winners

Contract Timeline

• Start date: 04 September 2026
• Date winner chosen: 29 July 2026
• Contracts concluded: 04 to 17 September 2026 (various)
• Duration: Unlimited
• Notice published: 25 September 2026 (OJ S 186/2026)
• Notice dispatch date: 24 September 2026
• Previous notice: 231_000665

Contract Overview

Servica Oy conducted an open procedure under the standard regime, governed by EU Directive 2014/24/EU.

Key features include:

• Four lots: LOT-0001 to LOT-0004
• Value of all contracts awarded in this notice: €30,000,000.00
• Duration: Unlimited
• Framework type: No framework agreement
• Evaluation: Price (100%) calculated by formula
• Winners: Multiple suppliers across four lots
• Subcontracting: Yes for several winners (value and percentage unknown)
• No EU funding
• Covered by GPA: Yes
• Strategic procurement: Human rights due diligence in global supply chains

Key Contract Details

• Main classification: 33000000 Medical equipments, pharmaceuticals and personal care products
• Additional classification: 60161000 Parcel transport services
• Place of performance: Pohjois-Savo, Finland (NUTS: FI1DB)
• Procedure identifier: be598831-3c1e-4ea4-9e9e-395947828b10
• Internal identifier: 231_000665
• Type of procedure: Open
• Accelerated procedure: No
• Legal basis: Directive 2014/24/EU
• Review body: Markkinaoikeus

Lot Structure

OSA 1 – Tubeless Hybrid Pump

• Internal identifier: 2026-047404-LOT-0001
• Description: Sensor-equipped tubeless insulin pumps with automatic insulin dosing (tubeless hybrid pumps); pumps and accessories, excluding sensors
• User estimates: Pohjois-Savo 30, new starts 70/year; Pohjois-Karjala 30, new starts 25/year; Etelä-Savo 48, new starts 30/year
• Winner: NordicInfu Care AB - Filial Finland (€1,700,000.00; Contract 231_000665_2_5)
• Tenders received: 2 (1 verified and inadmissible)
• Contract concluded: 04 September 2026
• Duration: Unlimited

OSA 2 – Tube-Based Hybrid Pump

• Internal identifier: 2026-047404-LOT-0002
• Description: Sensor-equipped tube-based insulin pumps with automatic insulin dosing (tube-based hybrid pumps); pumps and accessories, excluding sensors
• User estimates: Pohjois-Savo 957, new starts 100/year; Pohjois-Karjala 375, new starts 65/year; Etelä-Savo 346, new starts 30/year
• Winners: mylife Diabetes Care Finland Oy (€700,000.00; Contract 231_000665_2_4); Medtronic Finland Oy (€700,000.00; Contract 231_000665_2_3); Rubin Medical Oy (€700,000.00; Contract 231_000665_2_7)
• Tenders received: 5
• Contracts concluded: 07 and 15 September 2026
• Duration: Unlimited

OSA 3 – Sensors for Continuous Real-Time Sensing (Separate Glucose Monitoring)

• Internal identifier: 2026-047404-LOT-0003
• Description: Sensors for continuous real-time sensing, i.e. separate glucose monitoring
• User estimates (all sensor users – separate monitoring + device sensor users): Pohjois-Savo 4,500; Pohjois-Karjala 1,725; Etelä-Savo 1,400
• Winners: Abbott Oy (€2,470,000.00; Contract 231_000665_2_1); Mediq Suomi Oy (€2,470,000.00; Contract 231_000665_2_2); Medtronic Finland Oy (€2,470,000.00; Contract 231_000665_2_3); NordicInfu Care AB - Filial Finland (€2,470,000.00; Contract 231_000665_2_5); Roche Diagnostics Oy (€2,470,000.00; Contract 231_000665_2_6); Rubin Medical Oy (€2,470,000.00; Contract 231_000665_2_7)
• Tenders received: 11 (1 verified and inadmissible)
• Contracts concluded: 04 to 17 September 2026
• Duration: Unlimited

OSA 4 – Option: Medical Supply Distribution and Ordering System

• Internal identifier: 2026-047404-LOT-0004
• Description: Optional medical supply distribution (home delivery) and ordering system for use by medical supply unit staff or end users; offered by a tenderer who offers Lots 1-3; does not affect the comparison price; can be attached to the contract if offered and the buyer(s) decide to exercise the option
• Winners: mylife Diabetes Care Finland Oy (€16,667.00; Contract 231_000665_2_4); Medtronic Finland Oy (€16,667.00; Contract 231_000665_2_3); Roche Diagnostics Oy (€16,667.00; Contract 231_000665_2_6)
• Tenders received: 6
• Contracts concluded: 07 September 2026
• Duration: Unlimited

Lot Summary Table

Lot	Title	Value (€)	Winner	Tenders
1	OSA 1. Tubeless Hybrid Pump	1,700,000.00	NordicInfu Care AB - Filial Finland	2
2	OSA 2. Tube-Based Hybrid Pump	700,000.00 each	mylife Diabetes Care Finland Oy; Medtronic Finland Oy; Rubin Medical Oy	5
3	OSA 3. Sensors for Continuous Real-Time Sensing	2,470,000.00 each	Abbott Oy; Mediq Suomi Oy; Medtronic Finland Oy; NordicInfu Care AB - Filial Finland; Roche Diagnostics Oy; Rubin Medical Oy	11
4	OSA 4. Option: Medical Supply Distribution and Ordering System	16,667.00 each	mylife Diabetes Care Finland Oy; Medtronic Finland Oy; Roche Diagnostics Oy	6
Total		30,000,000.00

Scope of Supply

The framework covers the following supplies and services:

• OSA 1 – Tubeless Hybrid Pump: Sensor-equipped tubeless insulin pumps with automatic insulin dosing; pumps and accessories, excluding sensors
• OSA 2 – Tube-Based Hybrid Pump: Sensor-equipped tube-based insulin pumps with automatic insulin dosing; pumps and accessories, excluding sensors
• OSA 3 – Sensors: Sensors for continuous real-time sensing (separate glucose monitoring), for use both with hybrid pumps and as independent meters
• OSA 4 – Option: Medical supply distribution (home delivery) and ordering system (parcel transport services)
• Medical Equipments, Pharmaceuticals and Personal Care Products: Supplies under CPV 33000000

Special Procurement Conditions

• All Qualified Tenderers Selected: All tenderers meeting the minimum requirements of the tender request are selected as suppliers for the lots
• Priority Order: Tenders are prioritised based on the points obtained in the comparison, which compares the annual cost of the device and consumables; the priority order means, for example, that for the device part, the most cost-effective product offered for the intended use for the relevant patient group is examined first, and then the next in order, until a suitable product for the patient is found
• Product Selection or Change: The priority-based selection option is always checked for new patients or when an existing patient has a product change need; during the contract period, products already in use by a patient are changed only if the treatment need requires it; product selection or change is always made by the treating healthcare personnel
• Contract Change: The change of contract period does not mean that products in use by existing customers are changed without medical grounds if the product's supplier has been selected as contract supplier
• Sensor Quantities: Sensor consumption quantities and selection will also depend on the device selection of the future contract period (tube-based and tubeless sensor-equipped hybrid pump), as the hybrid pump system uses a sensor; the supplier states in its tender the sensors suitable for the device and, for sensors, the devices to which the sensor is suitable
• Selection Criteria: Priority order; in hybrid pump systems also the life-cycle costs of the hybrid pump system entity (pump & accessories, sensor cost, other costs); the tenderer's home delivery production possibilities and costs (option, by buyer); the final decision on the pump given to a patient is always made on medical grounds in the treating unit
• Consumption Estimates: The tender annex contains estimates of user numbers and new starts per year to support the tenderer's offer; the buyers do not commit to a specific consumption estimate; the final user number for the device during the contract period may be more or less
• Indefinite Contracts: Contracts are made for an indefinite period; the procurement value has been calculated with a 4-year consumption estimate
• Combining Contracts: Contracts can be combined by lot if a tenderer offers and is selected for multiple lots
• Binding Terms: The procurement contract agrees on the key terms so bindingly that the contract can be implemented during the contract period like a procurement contract: the price is confirmed bindingly and fixed in the procurement procedure, and only matters related to the exact quantity of products to be procured and their ordering and delivery remain open
• Option (OSA 4): The supplier who offers Lots 1-3 can offer medical supply distribution as an option for its chosen lot; this lot does not have to be offered and does not affect the comparison price; the option can be attached to the contract if offered and the buyer(s) decide to exercise the option
• Subcontracting: Subcontracting was declared for several winners (value and percentage unknown)

About the Contracting Authority

Servica Oy is a public undertaking operating in general public services in Finland, acting as group leader and central purchasing body.

• Legal type: Public undertaking
• Activity: General public services
• Registration number: 2947618-4
• Location: Kuopio, Finland (NUTS: FI1DB)
• Address: Saaristokatu 7, 70620 Kuopio
• Email: hankinnat@servica.fi
• Telephone: 0800 307 711

Co-Buyers:

• Etelä-Savon hyvinvointialue – Regional authority, Mikkeli, Finland (NUTS: FI1DA); Activity: Health
• Pohjois-Karjalan hyvinvointialue – Regional authority, Joensuu, Finland (NUTS: FI1DC); Activity: Health
• Pohjois-Savon hyvinvointialue – Regional authority, Kuopio, Finland (NUTS: FI1DB); Activity: Health

About the Winning Suppliers

NordicInfu Care AB - Filial Finland – SME, Espoo, Finland (NUTS: FI1B1); Winner of LOT-0001 and LOT-0003; Subcontracting: Yes (parcel handling and storage services, 63100000-0)

mylife Diabetes Care Finland Oy – Small enterprise, Masala, Finland (NUTS: FI1B1); Winner of LOT-0002 and LOT-0004; Subcontracting: Yes (transport support and auxiliary services, travel agency services, 63000000-9)

Medtronic Finland Oy – Large enterprise, Helsinki, Finland (NUTS: FI1B1); Winner of LOT-0002, LOT-0003 and LOT-0004; Subcontracting: No

Rubin Medical Oy – SME, Vantaa, Finland (NUTS: FI1B1); Winner of LOT-0002 and LOT-0003; Subcontracting: No

Abbott Oy – Large enterprise, Helsinki, Finland (NUTS: FI1B1); Winner of LOT-0003; Subcontracting: No

Mediq Suomi Oy – Large enterprise, Espoo, Finland (NUTS: FI1B1); Winner of LOT-0003; Subcontracting: No

Roche Diagnostics Oy – Large enterprise, Espoo, Finland (NUTS: FI1B1); Winner of LOT-0003 and LOT-0004; Subcontracting: Yes (transport services excluding waste transport, 60000000-8)

Evaluation Criteria

All lots use the same evaluation criterion:

• Price (100%): Hinta – calculated by formula

Procurement Analysis

• Procedure: Open procedure under the standard regime, governed by EU Directive 2014/24/EU
• Competition: 2 tenders (LOT-0001); 5 tenders (LOT-0002); 11 tenders (LOT-0003); 6 tenders (LOT-0004)
• Subcontracting: Yes for several winners (value and percentage unknown)
• No EU funding: The procurement was not financed with EU funds
• No framework agreement: No framework agreement
• No dynamic purchasing system used
• Accelerated procedure: No
• Strategic procurement: Human rights due diligence in global supply chains
• Review body: Markkinaoikeus
• Call for competition terminated: The call for competition has been terminated (contracts awarded)

Additional Procurement Facts

• The contract is covered by the WTO's Government Procurement Agreement (GPA)
• No EU funds were used for this procurement
• The value of all contracts awarded in this notice is €30,000,000.00
• The procurement is divided into four lots
• Price (100%) is the evaluation criterion for all lots
• 2 to 11 tenders were received per lot
• Winners include large enterprises and SMEs
• Subcontracting was declared for several winners
• Contracts are made for an indefinite period
• The procurement value has been calculated with a 4-year consumption estimate
• Contracts were concluded between 4 and 17 September 2026
• Strategic procurement includes human rights due diligence in global supply chains

Market & Industry Perspective

The Finnish public sector diabetes care equipment market features a mix of large international manufacturers and specialised national distributors. Hybrid insulin pumps and continuous glucose sensors are essential for diabetes care, enabling automatic insulin dosing and real-time glucose monitoring.

Key trends in this market include:

• Price focus: 100% price-based evaluation
• Mix of providers: Large enterprises and SMEs appointed
• Multi-lot structure: Four lots covering tubeless pumps, tube-based pumps, sensors and optional distribution
• Priority order: Tenders prioritised based on annual cost of device and consumables
• Medical decision-making: Final decision on the pump given to a patient is always made on medical grounds in the treating unit
• Indefinite contracts: Contracts made for an indefinite period
• Strategic procurement: Human rights due diligence in global supply chains

Economic Significance

At €30,000,000.00, this framework represents a significant investment in hybrid insulin pumps and continuous glucose sensors for the wellbeing services counties of Pohjois-Savo, Etelä-Savo and Pohjois-Karjala. The contract will:

• Support Diabetes Care: Provide hybrid insulin pumps and continuous glucose sensors
• Support Both Large Enterprises and SMEs: Winners include large enterprises and SMEs
• Provide Long-Term Stability: Contracts made for an indefinite period
• Ensure Product Availability: Multi-supplier framework across four lots
• Enable Operational Efficiency: Standardised hybrid pump and sensor supply
• Support Patient Care: Automatic insulin dosing and real-time glucose monitoring
• Support Strategic Objectives: Human rights due diligence in global supply chains

Future Procurement Opportunities

With this framework now in place, future opportunities include:

• Re-tender: Expected if the indefinite contracts are terminated or replaced
• Related Supplies: Additional hybrid pumps, sensors and medical supplies
• Subcontracting: Potential opportunities with framework winners
• Other Wellbeing Services Counties: Similar hybrid pump and sensor procurements
• Option (OSA 4): Potential exercise of the medical supply distribution and ordering system option

Opportunities for Suppliers

While this contract is awarded, opportunities remain for diabetes care equipment suppliers:

• Re-tender: Prepare for future procurement cycles
• Subcontracting: Potential opportunities with framework winners
• Related Supplies: Other hybrid pumps, sensors and medical supplies
• Other Finnish Wellbeing Services Counties: Similar hybrid pump and sensor procurements
• Option (OSA 4): Monitor medical supply distribution opportunities

What Businesses Should Watch

• Servica Oy's future procurement notices
• Other Finnish wellbeing services counties diabetes care tenders
• Hybrid insulin pump and continuous glucose sensor market trends
• Changes to Finnish procurement regulations
• Strategic procurement requirements (human rights due diligence)
• Option exercise decisions (OSA 4)

FinlandTenders.com Procurement Intelligence

This hybrid insulin pump and glucose sensor framework is a notable example of Finnish public sector healthcare procurement. Several features stand out:

• Scale: €30M value of all contracts awarded in this notice
• Price focus: 100% price-based evaluation
• Mix of winners: Large enterprises and SMEs
• Four lots: Tubeless hybrid pump, tube-based hybrid pump, sensors, and optional distribution
• Competition: 2 to 11 tenders per lot
• Indefinite contracts: Contracts made for an indefinite period
• Priority order: Tenders prioritised based on annual cost of device and consumables
• Strategic procurement: Human rights due diligence in global supply chains

For suppliers, this procurement highlights the importance of:

• Competitive pricing: 100% price-based evaluation
• Hybrid insulin pump and sensor expertise: Ability to supply tubeless and tube-based hybrid pumps and continuous glucose sensors
• Public sector experience: Understanding of Finnish wellbeing services county requirements
• Medical device capability: Ability to deliver automatic insulin dosing and real-time glucose monitoring
• Life-cycle cost awareness: Understanding of life-cycle costs of hybrid pump systems
• Strategic awareness: Understanding of human rights due diligence in global supply chains

Supplier Takeaways

• Offer competitive pricing – 100% of evaluation is price-based
• Demonstrate hybrid insulin pump and sensor supply capability
• Show automatic insulin dosing and real-time glucose monitoring capability
• Develop public sector experience with Finnish wellbeing services counties
• Demonstrate life-cycle cost awareness for hybrid pump systems
• Showcase strategic awareness of human rights due diligence
• Monitor Servica Oy and Finnish healthcare procurement opportunities
• Prepare for potential option exercise opportunities (OSA 4)

Key Takeaways

• Servica Oy awarded a €30,000,000.00 framework for hybrid insulin pumps and glucose sensors
• Four lots: OSA 1 (Tubeless hybrid pump), OSA 2 (Tube-based hybrid pump), OSA 3 (Sensors for continuous real-time sensing), OSA 4 (Option: medical supply distribution and ordering system)
• Duration: Unlimited (contracts made for an indefinite period)
• Evaluation: Price (100%) calculated by formula
• 2 to 11 tenders received per lot
• Winners: NordicInfu Care AB - Filial Finland; mylife Diabetes Care Finland Oy; Medtronic Finland Oy; Rubin Medical Oy; Abbott Oy; Mediq Suomi Oy; Roche Diagnostics Oy
• Winners include large enterprises and SMEs
• Subcontracting declared for several winners
• No EU funding
• Covered by GPA: Yes
• No framework agreement
• Strategic procurement: human rights due diligence in global supply chains
• Co-buyers: Etelä-Savon hyvinvointialue, Pohjois-Karjalan hyvinvointialue, Pohjois-Savon hyvinvointialue

Conclusion

This hybrid insulin pump and glucose sensor framework ensures that the wellbeing services counties of Pohjois-Savo, Etelä-Savo and Pohjois-Karjala have access to a broad range of diabetes care equipment from multiple suppliers. By appointing multiple suppliers across four lots, Servica Oy secures a diverse panel with the capability to deliver tubeless and tube-based hybrid pumps, continuous glucose sensors and optional medical supply distribution.

The 100% price-based evaluation reflects the equipment-driven nature of diabetes care procurement, where price is the primary differentiator among qualified suppliers. The multi-lot structure, the priority order based on annual cost, the medical decision-making by treating personnel and the strategic procurement objective of human rights due diligence reflect the specific operational and strategic context of diabetes care in the Finnish wellbeing services counties.

For suppliers, this procurement highlights the importance of competitive pricing, hybrid insulin pump and sensor expertise, public sector experience, medical device capability, life-cycle cost awareness and strategic awareness in winning Finnish public sector diabetes care equipment contracts.

Frequently Asked Questions

Q: What is Servica Oy?

Ans: A public undertaking operating in general public services in Finland, acting as group leader and central purchasing body for the wellbeing services counties.

Q: What is the value of the framework?

Ans: The value of all contracts awarded in this notice is €30,000,000.00.

Q: Who are the winners?

Ans: NordicInfu Care AB - Filial Finland (LOT-0001, LOT-0003); mylife Diabetes Care Finland Oy (LOT-0002, LOT-0004); Medtronic Finland Oy (LOT-0002, LOT-0003, LOT-0004); Rubin Medical Oy (LOT-0002, LOT-0003); Abbott Oy (LOT-0003); Mediq Suomi Oy (LOT-0003); Roche Diagnostics Oy (LOT-0003, LOT-0004).

Q: What supplies and services are covered?

Ans: Tubeless and tube-based hybrid insulin pumps, sensors for continuous real-time sensing (separate glucose monitoring) and an optional medical supply distribution and ordering system.

Q: What were the evaluation criteria?

Ans: Price (100%) calculated by formula.

Q: How long is the contract?

Ans: Contracts are made for an indefinite period.

Q: How many tenders were received?

Ans: 2 tenders (LOT-0001); 5 tenders (LOT-0002); 11 tenders (LOT-0003); 6 tenders (LOT-0004).

Q: Is this contract funded by the EU?

Ans: No, the procurement is not financed with EU funds.

Q: What is the review body?

Ans: Markkinaoikeus.

Q: What is the lot structure?

Ans: Four lots – LOT-0001 (OSA 1. Tubeless hybrid pump), LOT-0002 (OSA 2. Tube-based hybrid pump), LOT-0003 (OSA 3. Sensors for continuous real-time sensing), LOT-0004 (OSA 4. Option: medical supply distribution and ordering system).

Q: Is subcontracting allowed?

Ans: Yes, subcontracting was declared for several winners (value and percentage unknown).

Q: How are suppliers selected?

Ans: All tenderers meeting the minimum requirements are selected as suppliers; tenders are prioritised based on the points obtained in the comparison, which compares the annual cost of the device and consumables.

Q: What strategic procurement objective applies?

Ans: A social objective of human rights due diligence in global supply chains.

Q: Who are the co-buyers?

Ans: Etelä-Savon hyvinvointialue, Pohjois-Karjalan hyvinvointialue and Pohjois-Savon hyvinvointialue.

Source: EU Official Journal, Contract Award Notice 662256-2026, OJ S 186/2026, published 25 September 2026.

```